激活的T细胞通过巨细胞再教育来破坏瘤免疫抑制
Rosa Trotta1, Silvia Rivis2, Shikang Zhao1
1KU Leuven-VIB, Belgium.
Cancer discovery
|March 17, 2025
概括
在瘤巨细胞中,T细胞激活抑制了造血性前列腺素-D2合成酶 (HPGDS),这通常促进癌症生长. 向HPGDS可以增强抗瘤免疫力,并改善免疫治疗反应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 与瘤相关的巨细胞 (TAMs) 经常表现出前瘤功能.
- 前列腺素D2 (PGD2) 在瘤微环境中的作用是复杂的.
- T细胞激活对于抗瘤免疫是至关重要的,但可以在瘤微环境中被抑制.
研究的目的:
- 阐明T细胞激活影响黑色素瘤TAM功能的机制.
- 为了研究血液生成性前列腺素-D2合成酶 (HPGDS) 在调解TAM前瘤表型中的作用.
- 探索HPGDS作为克服免疫疗法耐药性的治疗目标.
主要方法:
- 对来自人类和小鼠黑色素瘤的瘤相关巨细胞 (TAMs) 的HPGDS转录的分析.
- 研究调节HPGDS中的TNFα信号通路.
- 通过DP1和DP2受体在TAM中评估前列腺素-D2 (PGD2) 自克林环.
- 对TAM表型和CD8+T细胞活动的遗传和药理HPGDS抑制的评估.
- 在患者和小鼠中,HPGDS表达水平与对αPD1免疫疗法的反应的相关性.
主要成果:
- 黑色素瘤中的T细胞激活通过TNFα信号传递抑制了TAM中的HPGDS转录.
- 在TAM中,HPGDS建立了PGD2自循环,维持它们的前瘤状态并抑制CD8+T细胞.
- 向HPGDS促进抗瘤TAM特征,增强CD8+T细胞的招募和功能,并使瘤对αPD1敏感.
- 由于HPGDS过度表达或TNFα阻断,通过维持瘤前的TAM表型,导致免疫疗法耐药性.
结论:
- 通过HPGDS,T细胞激活通过调节TAM功能来调节先天免疫系统.
- 在TAM中HPGDS/PGD2信号传递是驱动免疫疗法耐药性的关键机制.
- 向HPGDS是一个有希望的策略,可以克服αPD1耐药性并增强抗瘤免疫力.
相关概念视频
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Cytotoxic T Cells-mediated Immune Response
823
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
823
T Cell Types and Functions
740
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
740
Cell-mediated Immune Responses
66.6K
Overview
66.6K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
T Cell Activation and Clonal Selection
620
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
620


